Marex Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Buy
11,419
+8,532
+296% +$1.22M 0.01% 399
2025
Q4
$480K Buy
+2,887
New +$483K ﹤0.01% 575
2025
Q3
Sell
-24,300
Closed -$2.2M 1024
2025
Q2
$2.2M Buy
+24,300
New +$1.92M 0.02% 223
2024
Q4
Sell
-32,460
Closed -$1.7M 828
2024
Q3
$1.7M Buy
32,460
+26,729
+466% +$1.25M 0.04% 170
2024
Q2
$347K Buy
+5,731
New +$397K 0.01% 381

Other funds holding ALAB

Marex Group's ALAB Position: Q1 2026 in Review

Marex Group increased its Astera Labs (ALAB) stake by 296% in Q1 2026, buying an estimated $1.22M and bringing the position to 11,419 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #399.

Marex Group first reported a position in ALAB in Q2 2024 and has held it in 5 quarters since. The position peaked at $2.2M in Q2 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Marex Group held 11,419 shares of Astera Labs worth $1.25M as of Q1 2026.
  • Marex Group bought 8,532 Astera Labs shares in Q1 2026, an estimated $1.22M.
  • Astera Labs made up 0.01% of Marex Group's portfolio in Q1 2026, its #399 holding.
  • Marex Group first reported a position in Astera Labs in Q2 2024 and has held it in 5 quarters since.
  • Marex Group's Astera Labs position peaked at $2.2M in Q2 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.